Genevieve Kanter

Biography

Genevieve P. Kanter, PhD, is Associate Professor of Public Policy at the USC Price School of Public Policy.

She is an economist whose research focuses on the FDA and regulatory issues related to biomedical technologies; financial conflicts of interest; industry relationships and industry influence in medicine; and hospital and physician payment models.

Professor Kanter’s research and essays have been published in leading academic journals, including the New England Journal of Medicine, JAMA, and Health Affairs, and her work and expert commentary have been featured in major media outlets, including the New York Times, Wall Street Journal, Washington Post, Chicago Tribune, AP, NPR, and FiveThirtyEight.

She serves on Medicare Evidence Development & Coverage Advisory Committee (the federal advisory committee for Medicare coverage) and is on the Editorial Board of the journal BMC Medical Ethics.

Professor Kanter received a PhD in Economics and in Sociology from the University of Chicago; completed an NIH postdoctoral fellowship in health and demography at Princeton University; and completed research fellowships in health policy and ethics at Massachusetts General Hospital and Harvard University.

Selected Publications

• Kanter, G. P., Rekowski, J. R., & Kannarkat, J. T. (2024). Lessons from the Change Healthcare Ransomware attack. JAMA Health Forum, 5(9).
• Kanter, G. P., Ozluk, P., Chi, W., Fisch, M. J., Debono, D., Parikh, R. B., Jacobson, M., Bekelman, J. E., & DeVries, A. (2024). Cancer treatment before and after physician-pharmacy integration. JAMA Network Open, 7(5).
• Lau-Min, K. S., Wu, Y., Rochester, S., Bekelman, J. E., Kanter, G. P., & Getz, K. D. (2024).  Association between Oral Targeted Cancer Drug Net Health Benefit, uptake, and spending. JNCI: Journal of the National Cancer Institute, 116(9), 1479–1486.